[Effect of latamoxef on platelet aggregation in hemodialysis and continuous ambulatory peritoneal dialysis (CAPD) patients].
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009070:Moxalactam / Q000494:pharmacology*; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010974:Platelet Aggregation / Q000187:drug effects*; D006435:Renal Dialysis
D000900:Anti-Bacterial Agents; D009070:Moxalactam